Effective Tacrolimus Treatment for Patients with Non-Severe Aplastic Anemia That is Refractory/Intolerant to Cyclosporine A: A Retrospective Study

BACKGROUND: For symptomatic non-severe aplastic anemia (NSAA) patients who cannot afford anti-thymocyte globulin (ATG) or allogeneic hematopoietic stem cell transplantation (HSCT), tacrolimus (FK) may be an option if these patients do not respond or become tolerant to cyclosporine A (CsA). METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Yali, Huang, Yuzhou, Zhou, Wenzhe, Liu, Xinjian, Chen, Fangfei, Yang, Chen, Chen, Miao, Ruan, Jing, Han, Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779311/
https://www.ncbi.nlm.nih.gov/pubmed/33408460
http://dx.doi.org/10.2147/DDDT.S275975

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779311/
https://www.ncbi.nlm.nih.gov/pubmed/33408460
http://dx.doi.org/10.2147/DDDT.S275975

Ejemplares similares